An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder Treated With Quetiapine XR and/or Quetiapine IR

Trial Profile

An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder Treated With Quetiapine XR and/or Quetiapine IR

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jan 2013

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Bipolar disorders
  • Focus Therapeutic Use
  • Acronyms REED
  • Sponsors AstraZeneca
  • Most Recent Events

    • 08 May 2012 Actual end date 1 Apr 2012 added as reported by ClinicalTrials.gov.
    • 08 May 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top